ADAG Reports $0 Revenue, $0 EPS, Announces $0 Buyback, Presents AACR 2026 Data on Muzastotug Triple Combination Therapy for HCC and MSS CRC
Adagene Inc. American Depositary Shares · Now $3.78
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS